Immunoglobulin Therapy: Standardizing Approaches and Best Practices in Rare Diseases in the Managed Care Setting.
Although immunoglobulin is a life-saving therapy for many patients with immune deficiency disorders, it is expensive. Managed care, in consultation with experts in each indication, should use a rational approach to standardizing and prioritizing indications and regimens. New data on higher trough le...
| Publicado en: | Journal of Managed Care Medicine Vol. 14; no. 2; pp. 26 - 34 |
|---|---|
| Autor principal: | |
| Formato: | tables/charts Journal Article |
| Publicado: |
National Association of Managed Care Physicians, Inc.
2011
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | Although immunoglobulin is a life-saving therapy for many patients with immune deficiency disorders, it is expensive. Managed care, in consultation with experts in each indication, should use a rational approach to standardizing and prioritizing indications and regimens. New data on higher trough levels should be incorporated into managed care guidelines. |
|---|